Officer exercised or converted 100 DGX derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Nov 18, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Nov 20, 2025
OfficerOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001955265-25-000004
Added to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly IssuerQUEST DIAGNOSTICS INC Reporting personMark E Delaney Officer titleSVP & Chief Commercial Officer TableNon-derivative (Table I) Transaction dateNov 18, 2025 Acquired / disposedAcquired (A) Footnotes from the filing
- This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
Around the same time
Congressional tradeHeld by the filer's joint per the disclosure. Disclosed 38 days after the transaction; reported as an official range, not an exact amount.
A board member of Quest Diagnostics sold $240K of Quest Diagnostics shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.